Total Payments
$5,443
2024 Payments
$651.57
Companies
24
Transactions
287
Medicare Patients
3,583
Medicare Billing
$451,312
Payment Breakdown by Category
Food & Beverage$4,711 (86.5%)
Other$700.00 (12.9%)
Education$32.27 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,711 | 285 | 86.5% |
| Grant | $700.00 | 1 | 12.9% |
| Education | $32.27 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,130 | 66 | $0 (2024) |
| Lilly USA, LLC | $811.88 | 52 | $0 (2024) |
| Merck Sharp & Dohme LLC | $710.72 | 49 | $0 (2022) |
| GENZYME CORPORATION | $700.00 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $620.99 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $433.53 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $233.98 | 13 | $0 (2021) |
| PFIZER INC. | $99.65 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $96.75 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $91.08 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $651.57 | 39 | Lilly USA, LLC ($159.59) |
| 2023 | $345.60 | 17 | Novo Nordisk Inc ($104.81) |
| 2022 | $560.05 | 31 | Novo Nordisk Inc ($212.04) |
| 2021 | $390.18 | 22 | Novo Nordisk Inc ($225.87) |
| 2020 | $177.79 | 11 | Lilly USA, LLC ($50.85) |
| 2019 | $1,785 | 69 | GENZYME CORPORATION ($700.00) |
| 2018 | $805.46 | 49 | Merck Sharp & Dohme Corporation ($180.11) |
| 2017 | $727.61 | 49 | Merck Sharp & Dohme Corporation ($249.87) |
All Payment Transactions
287 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.59 | General |
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: DIABETES | ||||||
| 09/12/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Diabetes | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Obesity | ||||||
| 08/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.15 | General |
| 08/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: DIABETES | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.07 | General |
| 06/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 835 | 2,505 | $284,055 | $137,857 |
| 2022 | 17 | 1,026 | 2,682 | $300,950 | $146,238 |
| 2021 | 15 | 835 | 1,605 | $177,201 | $88,925 |
| 2020 | 17 | 887 | 1,828 | $220,334 | $78,292 |
Total Patients
3,583
Total Services
8,620
Medicare Billing
$451,312
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 983 | $97,317 | $49,977 | 51.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 302 | $61,933 | $27,072 | 43.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 57 | 427 | $32,879 | $16,516 | 50.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 222 | $31,967 | $12,706 | 39.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 84 | 84 | $17,176 | $11,218 | 65.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 27 | 174 | $17,052 | $7,030 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,546 | $2,548 | 45.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 66 | 66 | $2,575 | $2,094 | 81.3% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 48 | 48 | $4,656 | $1,834 | 39.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 12 | 12 | $2,380 | $1,570 | 65.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 66 | 66 | $2,768 | $1,348 | 48.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 26 | $2,288 | $1,084 | 47.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 20 | 20 | $774.00 | $630.63 | 81.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 19 | $1,178 | $621.11 | 52.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 12 | 12 | $996.00 | $603.36 | 60.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 12 | 14 | $1,151 | $560.04 | 48.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 11 | $1,419 | $446.05 | 31.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 77 | 801 | $81,702 | $38,825 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 274 | $56,098 | $23,255 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 153 | 290 | $42,340 | $17,421 | 41.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 58 | 400 | $31,600 | $16,418 | 52.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 57 | 311 | $30,478 | $14,250 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $19,914 | $13,017 | 65.4% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 22 | $7,264 | $3,984 | 54.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 55 | 105 | $6,825 | $3,490 | 51.1% |
About Dr. Sanjay Patel, M.D
Dr. Sanjay Patel, M.D is a Internal Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235178831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjay Patel, M.D has received a total of $5,443 in payments from pharmaceutical and medical device companies, with $651.57 received in 2024. These payments were reported across 287 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,711).
As a Medicare-enrolled provider, Patel has provided services to 3,583 Medicare beneficiaries, totaling 8,620 services with total Medicare billing of $451,312. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Bloomingdale, IL
- Active Since 06/06/2006
- Last Updated 03/21/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235178831
Products in Payments
- JARDIANCE (Drug) $627.78
- JANUVIA (Drug) $470.29
- Ozempic (Drug) $371.42
- TRULICITY (Drug) $273.94
- Rybelsus (Drug) $267.31
- FARXIGA (Drug) $252.16
- TRADJENTA (Drug) $217.51
- Tresiba (Drug) $180.10
- Victoza (Drug) $158.83
- RYBELSUS (Drug) $132.61
- XARELTO (Drug) $117.22
- INVOKANA (Drug) $116.76
- STEGLATRO (Drug) $115.05
- Cologuard Collection Kit (Device) $78.55
- HUMALOG (Drug) $77.64
- ENTRESTO (Drug) $77.20
- BASAGLAR (Drug) $66.77
- SYNJARDY (Drug) $63.34
- ELIQUIS (Drug) $61.92
- ADVAIR (Drug) $57.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bloomingdale
Dr. Aziz Ahmed, M.d, M.D
Internal Medicine — Payments: $12,894
Internal Medicine $12,894
Vanja Cuk, Md, MD
Internal Medicine — Payments: $8,808
Internal Medicine $8,808
Dr. Mahrukh Subhani, M.d, M.D
Internal Medicine — Payments: $2,723
Internal Medicine $2,723
Robert Hurst, Md, MD
Internal Medicine — Payments: $1,136
Internal Medicine $1,136
Sonal Patel, Do, DO
Internal Medicine — Payments: $753.69
Internal Medicine $753.69
Wahaj Ahmed, M.d, M.D
Internal Medicine — Payments: $670.83
Internal Medicine $670.83